Skip to main content
SpringerLink
Log in

Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock

  • Original research article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

From a theoretical point of view, cholecalciferol (vitamin D3) as a precursor of calcitriol, a representative of secosteroids, may have neuroprotective properties and affect seizure phenomena.

Methods

In the present study, interactions between cholecalciferol and three second generation antiepileptic drugs (oxcarbazepine, lamotrigine, and topiramate) were studied in the maximal electroshock test in mice. Effects of drugs on motor coordination, long-term memory and explorative behavior of animals were evaluated in the chimney test, passive-avoidance task and plus-maze test, respectively.

Results

Cholecalciferol applied ip at doses of 37.5–75 μg/kg significantly raised the electroconvulsive threshold. Cholecalciferol, administered at the subthreshold dose of 18.75 μg, potentiated the anticonvulsant activity of oxcarbazepine and lamotrigine, but did not change their brain concentrations, therefore the revealed interactions seem to be pharmacodynamic. Furthermore, the action of cholecalciferol was not dependent on its conversion to calcitriol. The anticonvulsant effect of topiramate was enhanced by cholecalciferol applied at the higher dose of 37.5 μg/kg, at which it also increased the brain level of topiramate. As regards adverse effects, cholecalciferol, antiepileptic drugs, and their combinations did not significantly impair motor coordination or long-term memory in mice. Moreover, cholecalciferol did not show either anxiolytic or anxiogenic properties.

Conclusion

Our findings show that cholecalciferol has not only its own anticonvulsant action but also enhances efficacy of certain antiepileptic drugs, at least in experimental conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kalueff AV, Eremin KO, Tuohimaa P. Mechanisms of neuroprotective action of vitamin D3. Biochemistry (Moscow) 2004;69(7):738–41.

    Article  CAS  Google Scholar 

  2. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13(3):100–5.

    Article  CAS  PubMed  Google Scholar 

  3. Teagarden DL, Meador KJ, Loring DW. Low vitamin D levels are common in patients with epilepsy. Epilepsy Res 2014;108(8):1352–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998;135(4):319–23.

    Article  CAS  PubMed  Google Scholar 

  5. Gupta MM, Grover DN. Hypocalcemia and convulsions. Postgrad Med J 1977;53(620):330–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Holló A, Clemens Z, Lakatos P. Epilepsy vitamin D. Int J Neurosci 2014;124(6): 387–93.

    Article  PubMed  Google Scholar 

  7. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999;40(3):173–7.

    Article  CAS  PubMed  Google Scholar 

  8. McGrath J. Does ‘imprinting’ with low prenatal vitamin D contributes to the risk of various adult disorders? Med Hypotheses 2001;56(3):367–71.

    Article  CAS  PubMed  Google Scholar 

  9. Janjoppi L, Katayama MH, Scorza FA, Folgueira MA, Brentani M, Pansani AP, et al. Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res Bull 2008;76(5):480–4.

    Article  CAS  PubMed  Google Scholar 

  10. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 2006;394(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  11. Siegel A, Malkowitz L, Moscowitz MJ, Christakos S. Administration of 1,25-hydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res 1984;298(1):125–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kalueff AV, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 2005;67(1– 2):156–60.

    Article  CAS  PubMed  Google Scholar 

  13. Holló A, Clemens Z, Kamondi A, Lakatos P, Szűcs A. Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav 2012;24(1):131–3.

    Article  PubMed  Google Scholar 

  14. Borowicz KK, Morawska M, Furmanek-Karwowska K, Luszczki JJ, Czuczwar SJ. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur. J. Pharmacol. 2007;573(1–3):111–5.

    Article  CAS  PubMed  Google Scholar 

  15. Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007;4(1):18–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96(2):99–113.

    CAS  PubMed  Google Scholar 

  17. Boissier JR, Tardy J, Diverres JC. Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee. Med Exp (Basel) 1960;3:81–4.

    Article  CAS  Google Scholar 

  18. Venault P, Chapouthier G, De Carvalho LP, Simiand J, Morre M, Dodd RH, et al. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature 1986;321(6073):864–6.

    Article  CAS  PubMed  Google Scholar 

  19. Komada M, Takao K, Miyakawa T. Elevated plus maze for mice. JoVE 2008;22(22):1088–91.

    Google Scholar 

  20. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2007;22(3):659–61.

    Article  PubMed  Google Scholar 

  21. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev 2008;13(1):6–20.

    PubMed  Google Scholar 

  22. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM, et al. hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001;21(1): 98–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nguyen TM, Lieberherr M, Fritsch J, Guillozo H, Alvarez ML, Fitouri Z, et al. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem 2004;279(9):7591–7.

    Article  CAS  PubMed  Google Scholar 

  24. Norman AW, Henry HL, Bishop JE, Song X, Bula C, Okamura AW. Different shapes of the steroid hormone 1α,25(OH)2-vitamin D3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 2001;66(3–5):147–58.

    Article  CAS  PubMed  Google Scholar 

  25. Zanatta L, Goulart PB, Gonçalves R, Pierozan P, Winkelmann-Duarte EC, Woehl VM, et al. 1α,25-dihydroxyvitamin D(3) mechanism of action: modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats. Biochim Biophys Acta 2012;1823(10):1708–19.

    Article  CAS  PubMed  Google Scholar 

  26. Boland R, De Boland AR, Buitrago C, Morelli S, Santillán G, Vazquez G, et al. Non-genomic stimulation of tyrosine phosphorylation cascades by 1,25(OH)(2)D(3) by VDR-dependent and -independent mechanisms in muscle cells. Steroids 2002;67(6):477–82.

    Article  CAS  PubMed  Google Scholar 

  27. Doroudi M, Olivares-Navarrete R, Hyzy SL, Boyan BD, Schwartz Z. Signaling components of the 1α,25(OH)2D3-dependent Pdia3 receptor complex are required for Wnt5a calcium-dependent signaling. Biochim Biophys Acta 2014;1843(11):2365–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Holick MF, Trvela TE, Holick SA, Schnoes HK, DeLuca HF, Gallagher BM. Synthesis of 1α-hydroxy[6-3H]vitamin D3 and its metabolism to 1α,25-dihydroxy[6-3H]vitamin D3 in the rat. J Biol Chem 1976;251(4):1020–1.

    CAS  PubMed  Google Scholar 

  29. Kułak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol J Pharmacol 2004;56(1):29–41.

    PubMed  Google Scholar 

  30. Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47(3):510–5.

    Article  CAS  PubMed  Google Scholar 

  31. Burne THJ, McGratf JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005;157(2): 299–308.

    Article  CAS  PubMed  Google Scholar 

  32. Foreman MM, Hanania T,Eller M. Anxiolytic effect sof lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. Eur J Pharmacol 2009;602(2–3):316–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathophysiology, Medical University of Lublin, Poland

    Kinga K. Borowicz & Marta Morawska

  2. Department of Gynecological Oncology and Gynecology, Medical University of Lublin, Poland

    Dorota Morawska

Authors
  1. Kinga K. Borowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorota Morawska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marta Morawska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kinga K. Borowicz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borowicz, K.K., Morawska, D. & Morawska, M. Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. Pharmacol. Rep 67, 875–880 (2015). https://doi.org/10.1016/j.pharep.2015.01.012

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2015.01.012

Keywords

Search

Navigation